Ky. activists voice concern over patent expiry of OxyContin

01/14/2013 | United Press International

Activists are worried that generics that lack the abuse-resistant protections of of Purdue Pharma's painkiller OxyContin will flood Kentucky after its patent expires in April. "You'll see a lot more oxycodone abuse again. You'll see a lot of overdoses. You'll see the ER visits. You'll see the funeral homes pick up business," activist and recovering addict Joshua Huffman said.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC